medigraphic.com
ISSN 1817-5996 (Electronic)

2012, Number 19

<< Back Next >>

Rev Cub de Reu 2012; 14 (19)

Updates in the pathogenesis of the septic arthritis

Hernández CMV, Torres LAM, Hernández CIM

Language: Spanish
References: 37
Page:
PDF size: 78.40 Kb.


ABSTRACT

Septic arthritis infection with resulting inflammation within a joint is an emergency. Not only can it rapidly destroy a joint or irreversibly impair joint function, it may be fatal. In people of all ages, septic arthritis is usually caused by staphylococci (particularly Staphylococcus aureus). wich elaborate several extracellular and cell-mediated factors that may be important virulence determinants in septic arthritis. The pathogenesis of acute septic arthritis is multifactorial and depends on the interaction of the host immune response and the adherence factors, toxins, and immunoavoidance strategies of the invading pathogen. By taking into account the steps of bacterial colonization, infection and induction of the host inflammatory response. This review will help us to gain a greater understanding of this joint disease.


REFERENCES

  1. Riley J., Smith L., Schurman D.J. Septic arthritis. Arthritis Rheum. 2005; 33(4): 533-41.

  2. Williams R.J., Smith L., Schurman D.J. Septic Arthritis. Arth and Rheum. 2005; 33(4): 533-41.

  3. Zeller J.L., Lynm C., Glass R.M. Septic Arthritis. JAMA 2007; 297:1.

  4. Dubost JJ, Soubrier M, Sauvezie B. Pyogenic arthritis in adults. Joint Bone Spine. 2000; 67(1):11-21

  5. Ogunlusi JD, Ogunlusi OO, Oginni LM, Olowookere JA. Septic arthritis in a Nigerian tertiary hospital. Iowa Orthop J. 2006; 26: 45-7

  6. Pertuiset E. [Acute septic arthritis] Rev Prat. 2007 May 15; 57(9)37- 41.

  7. Ross J.J. Septic arthritis. Infect Dis Clin North Am. 2005; 19(4): 799-817.

  8. Carpenter CR, Schuur JD, Everett WW, Pines JM.Evidence-based diagnostics: adult septic arthritis. Acad Emerg Med. 2011 Aug; 18(8):781-96.

  9. Sadowski C.M., Gabay C. Septic Arthritis. Rev Med Suisse. 2006; 2(57): 2- 3.

  10. Abid N., Bhatti M. Septic arthritis in a tertiary care hospital. A J Pak Med Assoc. 2006; 56(3): 95-8.

  11. Duggal L, Khosla P.Etiological presentation of inflammatory arthritis. J Assoc Physicians India. 2011 Feb; 59: 87-90.

  12. Colectivo de autores Inmunología Celular y Molecular. 2da Parte. 2006. La Habana. Capítulo 16. Inmunidad frente a los microorganismos. Sección IV La inmunidad en la defensa y la enfermedad: 380- 84.

  13. Mathews C.J., Weston V.C., Kingsley G.H., Coakley G. Future management of septic arthritis. Future Rheumatology. 2008; Febr. 3(1): 23- 27.

  14. Ernst AA, Weiss SJ, Tracy LA, Weiss NR.Usefulness of CRP and ESR in predicting septic joints. South Med J. 2010 Jun; 103 (6):522-6.

  15. Breedveld FC, Lafeber G. Phagocitosis and intracellular killing of Staphylococcus aureus by polimorphonuclear cells from synovial fluid of patients with rheumatoid arthritis. Arthr And Rheuma. 2005; 29(2): 166-73.

  16. Kanangat S, Postlethwaite A, Hasty K, Kang A, SmeltzerM, Appling W, Schaberg D. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther. 2006; 8(6): R176

  17. Kauss T., Moynet D., Rmbert J. Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis. Arth Resear And Thera. 2008; 10: R 19.

  18. Cassat JE, Lee CY. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol. 2007; 391: 460-77.

  19. Campbell S. J., Deshmukh H. S., Nelson C. L., In-Gyu Bae, Stryjewski M. E., Federspiel J J., Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections. J.Clin Microbiol. 2008; 46(2): 34- 40.

  20. Josefsson Elisabet, Juuti Katri, Bokarewa Maria, Kuusela Pentti .The Surface Protein Pls of Methicillin-Resistant Staphylococcus aureus Is a Virulence Factor in Septic Arthritis. Infect Immun. 2005 May; 73(5): 2812– 2817.

  21. Chang WS, Chiu NC, Chi H, Li WC, Huang FY. Comparison of the characteristics of culture-negative versus culture-positive septic arthritis in children. J Microbiol Immunol Infect. 2005; Jun; 38(3):189- 93.

  22. Oettinger CW, D'souza MJ.Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition. J Microencapsul. 2012 Feb 21. [Epub ahead of print]

  23. Davis D. Management of bone and joint infections due to Staphylococcus aureus. 2005; 35: 79- 96.

  24. Cheryl M. Treatment of septic arthritis. Can Med Assoc J 2007; 177(8): 45- 53.

  25. Ward J., Cohen A, S., Bauer W. The diagnosis and therapy of suppurative arthritis. Arthr And Rheum 2005; 3(6): 522-35.

  26. Mac Kenzie I., Lever A. Management of sepsis. BMJ 2007;335: 929-32.

  27. Mathews C.J., Kinngstey G., Field M. Management of septic arthritis: a systematic review. Ann Reum Dis. 2007; (66): 67- 72.

  28. Coakley G., Mathews C., Field M., Jones A., Kingsley G., Walker D., Phillips M.,et.al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology. 2006; 45(8): 13- 5.

  29. Ross J. J. , Davidson L. Methicillin-resistant Staphylococcus aureus septic arthritis: an emerging clinical syndrome. Rheumatol. 2005; 44(9): 12.

  30. Beam JW, Buckley B. Community-Acquired Methicillin-Resistant Staphylococcus aureus: Prevalence and Risk Factors. J Athl Train. 2006; 41(3):337-40.

  31. Vostrel P, Legout L, Hoffmeyer P. [Septic arthritis (non gonococcal) of the adult: practical aspects] Rev Med Suisse. 2006; 2(92):2924-30.

  32. Kaandorp C.J., Kirjnen P., Bernelot H.J., Habbema J. The outcome of bacterial arthritis. A prospective community –based study. Arth And Rheum. 2005; 40(5): 884-92.

  33. Li S.F., Casssidy C., Chang C., Gharib S., Torres J. Diagnostic utility of laboratory test in septic arthritis. Emerg Med Jour. 2007; 24: 62- 4.

  34. Wei-Yao Wang, Shih-Yi Lee, Tzong-Shi Chiueh, and Jang-Jih Lu. Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis . J Clin Microbiol. 2009; 47(11): 3617–23.

  35. Konno A, Kanno M, Suzuki E, Kashiwabara T, Ishikawa A, Fujiyama J. Self-limited septic arthritis caused by Staphylococcus aureus. Pediatr.Int. 2010; 52(3):496-8.

  36. De Leo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections.Infect.DIs.Clin.North Am. 2009 Mar; 23(1):17-25.

  37. Gjertsson I, Jonsson IM, Peschel A, Tarkowski A, Lindholm C. Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice. J.Infect.Dis.2012; 205 (2):305-11.




2020     |     www.medigraphic.com